Trial reportJournal of medical Internet research2025
Impact of Ecological Momentary Assessment Participation on Short-Term Smoking Cessation: quitSTART Ecological Momentary Assessment Incentivization Randomized Trial.
Trial report in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Compliance With Ecological Momentary Assessment Among Patients With Cancer: Systematic Review and Meta-Analysis.Journal of medical Internet research · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background: Cigarette smoking is the leading cause of preventable mortality in the United States. Cessation interventions delivered through smartphone apps can reach large populations of individuals who smoke. Ecological momentary assessment (EMA), a feature often included in existing cessation apps, can be used to track behaviors and other important constructs and to inform just-in-time interventions. However, the isolated influence of EMA engagement on smoking cessation is unknown. In addition, the implications of incentivizing the use of EMA for cessation outcomes are currently unknown. The National Cancer Institute's publicly available smoking cessation app, quitSTART, includes a 2-week voluntary EMA protocol (42 total EMA prompts), which provides an opportunity to explore the impact of EMA incentivization on smoking cessation. Objective: This study aimed to examine the influence of app-based EMA participation on smoking cessation for people who are incentivized to use EMA compared with those who are not incentivized (representing the current implementation of EMA within quitSTART). Methods: In total, 152 US adults were recruited from web, social media, and SMS text message sources into a randomized controlled trial. All eligible participants were randomized to either nonincentivized EMA or incentivized EMA. Participants completed baseline, 2-week, and 4-week assessments. The primary outcome of interest was 7-day point prevalence abstinence measured at 2 and 4 weeks after app download. Average EMAs completed by arm were compared using a t test. Firth logistic regression modeling was used to determine the association between arm and smoking abstinence at 2 and 4 weeks, adjusted for smoking frequency and concurrent use of other tobacco products. Results: The mean number of EMAs completed was 13.3 (range 0-40, SD 11.2) in the incentivized arm and 4.7 (range 0-28, SD 5.8) in the nonincentivized arm (P<.001). Cessation rates were 9% and 20.3% at 2 weeks (P=.06), and 17.5% and 36.6% at 4 weeks (P=.01) in the incentivized arm and nonincentivized arm, respectively. Study arm was not associated with cessation in the adjusted models (adjusted odds ratio [OR] at 2 weeks 0.60, 95% CI 0.21-1.73; adjusted OR at 4 weeks 0.51, 95% CI 0.22-1.19). Conclusions: This study attempted to isolate and examine the effect of incentivizing EMA engagement on smoking cessation success for adults using a smartphone app to quit. While participants randomized to incentivization of EMA showed higher engagement with this feature, our findings suggest that there was no additional short-term cessation benefit from this engagement. Crude analyses found a potential benefit for allowing autonomy over the use of app features, despite the ability of EMA completion to provide real-time, tailored cessation support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.